The cost-effectiveness of rotavirus vaccination in Australia (Q44902395)

7 December 2017

The cost-effectiveness of rotavirus vaccination in Australia (English)

1 reference

cost-effectiveness analysis

7 December 2017

0 references

1 reference

5

C Raina MacIntyre

1 reference

7 December 2017

3

Kristine Macartney

1 reference

7 December 2017

Anthony T Newall

1

1 reference

7 December 2017

Philippe Beutels

series ordinal

2

1 reference

7 December 2017

James Wood

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

23 October 2007

1 reference

7 December 2017

1 reference

7 December 2017

25

1 reference

7 December 2017

52

1 reference

7 December 2017

8851-8860

1 reference

Burden of severe rotavirus disease in Australia.

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

The burden of rotavirus-related illness among young children on the Australian health care system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Cost effectiveness of rotavirus vaccination in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Economic Impact of Immunization Against Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

The national Perinatal Hepatitis B Prevention Program, 1994-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Cost-effectiveness analysis of a rotavirus immunization program for the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

[Potential cost effectiveness of a rotavirus vaccine in Chile]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Cost-effectiveness and potential impact of rotavirus vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Estimating the number of deaths with rotavirus as a cause in England and wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

The promise of new rotavirus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Quality of life measurement in children and adolescents: issues, instruments, and applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Comments on the Prosser et al Approach to Value Disease Reduction in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Measurement of health-related quality of life in survivors of cancer in childhood in Central America: feasibility, reliability, and validity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Parental perspectives of the health status and health-related quality of life of teen-aged children who were extremely low birth weight and term controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Economic impact of healthcare-associated rotavirus infection in a paediatric hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Timeliness of childhood immunisation in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

Cost-effectiveness analysis of a rotavirus immunization program for the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Rotavirus gastroenteritis in the Northern Territory, 1995-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.10.009

1 reference

7 December 2017

1 reference